A detailed history of Mosley Wealth Management transactions in Abb Vie Inc. stock. As of the latest transaction made, Mosley Wealth Management holds 3,735 shares of ABBV stock, worth $760,259. This represents 0.55% of its overall portfolio holdings.

Number of Shares
3,735
Previous 3,828 2.43%
Holding current value
$760,259
Previous $697 Million 8.1%
% of portfolio
0.55%
Previous 0.65%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024

SELL
$154.79 - $180.76 $14,395 - $16,810
-93 Reduced 2.43%
3,735 $641 Million
Q1 2024

Apr 15, 2024

SELL
$159.82 - $182.1 $12,465 - $14,203
-78 Reduced 2.0%
3,828 $697 Million
Q4 2023

Feb 14, 2024

BUY
$137.6 - $154.97 $537,465 - $605,312
3,906 New
3,906 $605 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $360B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Mosley Wealth Management Portfolio

Follow Mosley Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mosley Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Mosley Wealth Management with notifications on news.